Premium
Epstein‐Barr virus‐associated haemophagocytic lymphohistiocytosis in Wiskott‐Aldrich syndrome
Author(s) -
Pasic S,
Micic D,
Kuzmanovic M
Publication year - 2003
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2003.tb02548.x
Subject(s) - wiskott–aldrich syndrome , medicine , hemophagocytic lymphohistiocytosis , primary immunodeficiency , immunology , immunodeficiency , epstein–barr virus , digeorge syndrome , immunodeficiency syndrome , bone marrow , histiocytosis , virus , disease , pathology , immune system , biology , biochemistry , psychiatry , gene
A patient with Wiskott‐Aldrich syndrome who developed Epstein‐Barr virus‐associated haemophagocytic lymphohistiocytosis (EBV‐HLH) is described in this study. At 4 mo of age the patient developed fever associated with bicytopenia and splenomegaly. Analysis of a bone marrow specimen revealed extensive haemophagocytosis, and in situ hybridization for EBV of the bone marrow specimen using an EBV‐encoded RNA probe was positive. Diagnosis of EBV‐HLH was established and immunotherapy with HLH‐94 protocol was started. HLH has been described in patients with other well‐defined primary immunodeficiencies such as X‐linked lymphoproliferative syndrome, Chediak‐Higashi syndrome and Griscelli disease. Also, HLH was reported recently in severe combined immunodeficiency and DiGeorge syndrome. Conclusion : The possibility of an underlying primary immunodeficiency should be considered in paediatric patients who present with HLH during infancy.